supp.fit

Kombucha

6 benefits mapped to clinical evidence across supplements.

Benefit Evidence

H2O2 -19%

No other changes

59 people

LAP -8.7; IL-6 rise blunted

Better saliva microbes; heart risk

59 people

LAP -8.7; IL-6 blunted

Oral microbiota diversity shifted

59 people

LAP −8.7; IL-6 rise blunted

Saliva diversity up; pathogens down

59 people

No bloating/gas impact

No bloating/gas change

40 people

Stool frequency +42%

Firmer stools, less incomplete

Bowel emptying -0.47

40 people

Research sources

Antioxidant (1)
  1. Effect of regular green tea (Camellia sinensis) kombucha consumption on oxidative stress and endothelial health in individuals with excess body weight: a randomized controlled trial

    PubMed ID: 40637142

    Statistically significant reduction in plasma H2O2 (≈19%) indicates a measurable antioxidant effect, though limited to one marker.

Heart health (1)
  1. Green Tea Kombucha Impacts Inflammation and Salivary Microbiota in Individuals with Excess Body Weight: A Randomized Controlled Trial

    PubMed ID: 39339787

    Decrease in LAP is associated with lower cardiometabolic risk, supporting a heart‑health signal.

Metabolism (1)
  1. Green Tea Kombucha Impacts Inflammation and Salivary Microbiota in Individuals with Excess Body Weight: A Randomized Controlled Trial

    PubMed ID: 39339787

    Reduced LAP (lipid‑accumulation product) in overweight adults indicates a clinically relevant improvement in a metabolic/cardiometabolic marker.

Oral health (1)
  1. Green Tea Kombucha Impacts Inflammation and Salivary Microbiota in Individuals with Excess Body Weight: A Randomized Controlled Trial

    PubMed ID: 39339787

    Increased salivary bacterial richness and reduced abundance of some pathogenic oral species could plausibly improve oral ecology/freshness.

Bloating & gas (1)
  1. [Efficacy of newly developed kombucha-based specialized food product for treatment of constipation-predominant irritable bowel syndrome]

    PubMed ID: 36394933

    Improved stool frequency and reduced feeling of incomplete emptying in IBS‑C likely reduce bloating for affected individuals.

Digestive support (1)
  1. [Efficacy of newly developed kombucha-based specialized food product for treatment of constipation-predominant irritable bowel syndrome]

    PubMed ID: 36394933

    Pasteurized kombucha with added inulin produced clear clinical improvements in stool frequency, consistency, and reduced incomplete emptying in IBS‑C.

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Kombucha

Search all

4 products whose verified label declares Kombucha — not every bottle that mentions it in a title.

Being studied right now

Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.